Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 993

1.

The role of renal proximal tubule transport in the regulation of blood pressure.

Horita S, Nakamura M, Suzuki M, Satoh N, Suzuki A, Homma Y, Nangaku M.

Kidney Res Clin Pract. 2017 Mar;36(1):12-21. doi: 10.23876/j.krcp.2017.36.1.12. Epub 2017 Mar 31. Review.

2.

Type D personality as a predictor of self-efficacy and social support in patients with type 2 diabetes mellitus.

Shao Y, Yin H, Wan C.

Neuropsychiatr Dis Treat. 2017 Mar 20;13:855-861. doi: 10.2147/NDT.S128432. eCollection 2017.

3.

Epidemiology and outcomes of hypoglycemia in patients with advanced diabetic kidney disease on dialysis: A national cohort study.

Chu YW, Lin HM, Wang JJ, Weng SF, Lin CC, Chien CC.

PLoS One. 2017 Mar 29;12(3):e0174601. doi: 10.1371/journal.pone.0174601. eCollection 2017.

4.

Retrospective analysis of the overt proteinuria diabetic kidney disease in the treatment of modified Shenzhuo formula for 2 years.

Chen H, Guo J, Zhao X, He X, He Z, Zhao L, Tong X.

Medicine (Baltimore). 2017 Mar;96(12):e6349. doi: 10.1097/MD.0000000000006349.

5.

Effects of Apolipoprotein E Isoforms in Diabetic Nephropathy of Chinese Type 2 Diabetic Patients.

Jiang Y, Ma L, Han C, Liu Q, Cong X, Xu Y, Zhao T, Li P, Cao Y.

J Diabetes Res. 2017;2017:3560920. doi: 10.1155/2017/3560920. Epub 2017 Feb 23.

6.

A Proposal for an Out-of-Range Glycemic Population Health Safety Measure for Older Adults With Diabetes.

Pogach L, Tseng CL, Soroka O, Maney M, Aron D.

Diabetes Care. 2017 Apr;40(4):518-525. doi: 10.2337/dc16-0953. Epub 2016 Nov 15.

PMID:
28325799
7.

Diabetes and Aging: Unique Considerations and Goals of Care.

Kalyani RR, Golden SH, Cefalu WT.

Diabetes Care. 2017 Apr;40(4):440-443. doi: 10.2337/dci17-0005. No abstract available.

PMID:
28325794
8.

Learning Effective Treatment Pathways for Type-2 Diabetes from a clinical data warehouse.

Vashisht R, Jung K, Shah N.

AMIA Annu Symp Proc. 2017 Feb 10;2016:2036-2042. eCollection 2016.

9.

The Effect of Sitagliptin on the Regression of Carotid Intima-Media Thickening in Patients with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation.

Mita T, Katakami N, Shiraiwa T, Yoshii H, Gosho M, Shimomura I, Watada H.

Int J Endocrinol. 2017;2017:1925305. doi: 10.1155/2017/1925305. Epub 2017 Jan 17.

10.

Assessment of changes in insulin requirement in patients of type 2 diabetes mellitus on maintenance hemodialysis.

Sudha MJ, Salam HS, Viveka S, Udupa AL.

J Nat Sci Biol Med. 2017 Jan-Jun;8(1):64-68. doi: 10.4103/0976-9668.198348.

12.

Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study.

Carlsson LM, Sjöholm K, Karlsson C, Jacobson P, Andersson-Assarsson JC, Svensson PA, Larsson I, Hjorth S, Neovius M, Taube M, Carlsson B, Peltonen M.

Lancet Diabetes Endocrinol. 2017 Apr;5(4):271-279. doi: 10.1016/S2213-8587(17)30061-X. Epub 2017 Feb 23.

PMID:
28237791
14.

Lipids: A Suitable Therapeutic Target in Diabetic Neuropathy?

Perez-Matos MC, Morales-Alvarez MC, Mendivil CO.

J Diabetes Res. 2017;2017:6943851. doi: 10.1155/2017/6943851. Epub 2017 Jan 16. Review.

15.

Hyperglycemia effect on coronary disease in patients with metabolic syndrome evaluated by intracoronary ultrasonography.

Bonamichi BD, Parente EB, Campos AC, Cury AN, Salles JE.

PLoS One. 2017 Feb 10;12(2):e0171733. doi: 10.1371/journal.pone.0171733. eCollection 2017.

16.

Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study.

Saremi A, Howell S, Schwenke DC, Bahn G, Beisswenger PJ, Reaven PD; VADT Investigators..

Diabetes Care. 2017 Apr;40(4):591-598. doi: 10.2337/dc16-1875. Epub 2017 Feb 1.

PMID:
28148544
17.

Cardiovascular safety of non-insulin pharmacotherapy for type 2 diabetes.

Xu J, Rajaratnam R.

Cardiovasc Diabetol. 2017 Feb 2;16(1):18. doi: 10.1186/s12933-017-0499-5. Review.

18.

Advances in the management of cardiovascular risk for patients with type 2 diabetes: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes.

Schernthaner G, Jarvis S, Lotan C, Prázný M, Wanner C, Wascher TC.

Ther Clin Risk Manag. 2017 Jan 13;13:69-79. doi: 10.2147/TCRM.S121804. eCollection 2017.

19.

Prevention of complications in type 2 diabetes: is drug glucose control evidence based?

Boussageon R, Pouchain D, Renard V.

Br J Gen Pract. 2017 Feb;67(655):85-87. doi: 10.3399/bjgp17X689317. No abstract available.

PMID:
28126879
20.

Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal (CANVAS-R): A randomized, placebo-controlled trial.

Neal B, Perkovic V, Matthews DR, Mahaffey KW, Fulcher G, Meininger G, Erondu N, Desai M, Shaw W, Vercruysse F, Yee J, Deng H, de Zeeuw D; CANVAS-R Trial Collaborative Group..

Diabetes Obes Metab. 2017 Mar;19(3):387-393. doi: 10.1111/dom.12829. Epub 2017 Jan 25.

Supplemental Content

Support Center